https://scholars.lib.ntu.edu.tw/handle/123456789/572442
標題: | Efficacy of intrathecal drug delivery system for refractory cancer pain patients: A single tertiary medical center experience | 作者: | CHIH-PENG LIN WEN-YING LIN FENG-SHENG LIN Lee Y.-S. Jeng C.-S. WEI-ZEN SUN |
關鍵字: | Analgesia; Analgesics; ECOG; Morphine; Neoplasm; Pain management; Quality of life | 公開日期: | 2012 | 卷: | 111 | 期: | 5 | 起(迄)頁: | 253-257 | 來源出版物: | Journal of the Formosan Medical Association | 摘要: | Background/Purpose: Between 10% and 20% of cancer pain patients fail to obtain adequate pain relief despite comprehensive medical management. The totally implantable programmable intrathecal drug delivery system (IDDS) is an attractive option for managing refractory cancer pain. In suitable patients, IDDS can provide reliable long-term analgesia without any permanent nerve or plexus destruction. IDDS can also allow patient care on an outpatient basis. In Taiwan, however, the experience of using IDDS in terminally ill cancer patients is very limited. Methods: This retrospective study, describes experience of managing totally implantable programmable IDDS in 6 refractory cancer pain patients including patient selection, intraspinal morphine trial, surgical techniques, complications, and drug adjustment. Pain scores and functional status were compared before and after IDDS. Results: By delivering liberal dose of intrathecal morphine, patients' pain scores decreased from 10 to 3.5. Due to much better pain control and improved quality of life, Eastern Cooperative Oncology Group performance status also improved in 4/6 patients. During the mean 5 ± 4.1 months of follow-up, two patients experienced pocket seroma, and resolved spontaneously after short-term abdominal binder compression. Otherwise, no serious complication was noted. Conclusion: Intrathecal morphine delivery by using totally implantable programmable IDDS is an effective method to relieve refractory cancer pain. ? 2012. |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-84862802274&doi=10.1016%2fj.jfma.2011.03.005&partnerID=40&md5=657dedaa008014d80d4c41dfeee42f53 https://scholars.lib.ntu.edu.tw/handle/123456789/572442 |
ISSN: | 0929-6646 | DOI: | 10.1016/j.jfma.2011.03.005 | SDG/關鍵字: | morphine; adult; aged; analgesia; article; cancer pain; cancer palliative therapy; clinical article; clinical assessment tool; compression therapy; disease severity; drug delivery system; Eastern Cooperative Oncology Group performance status; female; follow up; human; intrathecal drug delivery system; male; outcome assessment; pain assessment; quality of life; refractory cancer pain; retrospective study; seroma; tertiary health care; Adult; Aged; Analgesics, Opioid; Female; Follow-Up Studies; Humans; Infusion Pumps, Implantable; Infusions, Spinal; Male; Middle Aged; Morphine; Neoplasms; Pain Measurement; Pain, Intractable; Patient Selection; Quality of Life; Retrospective Studies; Treatment Outcome |
顯示於: | 醫學院附設癌醫中心醫院(臺大癌醫) |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。